Does DISITAMAB VEDOTIN Cause Myelosuppression? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Myelosuppression have been filed in association with DISITAMAB VEDOTIN. This represents 21.4% of all adverse event reports for DISITAMAB VEDOTIN.
12
Reports of Myelosuppression with DISITAMAB VEDOTIN
21.4%
of all DISITAMAB VEDOTIN reports
0
Deaths
9
Hospitalizations
How Dangerous Is Myelosuppression From DISITAMAB VEDOTIN?
Of the 12 reports, 9 (75.0%) required hospitalization, and 1 (8.3%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DISITAMAB VEDOTIN. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does DISITAMAB VEDOTIN Cause?
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)